Helmy Eltoukhy
Disclosed holdings of Helmy Eltoukhy as of 2026-10-01: 4.08M shares of Guardant Health (GH), worth about $645M at the last close. From SEC Form 4 filings; not…
What Helmy Eltoukhy reported holding
As of the latest filing on , Helmy Eltoukhy reported holding 4,082,448 shares of Guardant Health (GH), worth about $645M at the last close of $158 (Oct 19, 2026): 2,123,499 held directly and 1,958,949 through a shares held by helmy a. eltoukhy revocable trust.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Guardant Health GH | 4,082,448 | 2.12M direct · 1.96M shares held by helmy a. eltoukhy revocable trust | $158 | $645M | Oct 1, 2026 |
Is this Helmy Eltoukhy’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Insider buying and selling since 2019
Helmy Eltoukhy bought shares on the open market in 2021 and 2023, and has not bought since 2023. Sales in 4 of the 8 years since 2019.
Helmy Eltoukhy reported 10 open-market purchases and 192 sales since 2019; purchases in 2 different years, most recently 2023.
| Year | Bought | Sold |
|---|---|---|
| 2025 | — | 2×2 trades |
| 2023 | 2×2 trades | — |
| 2021 | 8×8 trades | 107×107 trades |
| 2020 | — | 27×27 trades |
| 2019 | — | 56×56 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. The amounts, the people and every filing are in OQRO Pro.
The company behind these filings
- Guardant Health GH
Helmy Eltoukhy reported 10 open-market purchases and 192 sales here, 2019 to 2025.
- Market value
- $21.2B
- Last close
- $157.88
- 12 months
- +141.2%
- Against the S&P 500
- +125.8 pts
- Net margin
- -42.4%
- Revenue (last year)
- $982M
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
Trades disclosed
Latest trade
Largest trade
Companies
Every disclosed trade
Every trade this person has disclosed
Newest first, each one linked to the filing it came from.
Free account: get the written context of this page. Already a member? Sign in
What this page holds
- Every disclosed trade, newest first
- How purchases did after they were reported
- Companies and committees involved
- A link to every official filing
What OQRO is
OQRO reads the public record for US-listed companies — insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings, and federal contract awards — and puts each one in plain words next to the filing it came from. It describes what was disclosed. It does not give investment advice or tell you what to buy.
Want to see real filings before you pay? The home page shows live ones, free, with the link to each source document.
Questions about Helmy Eltoukhy's trades
Has Helmy Eltoukhy bought shares on the open market?
Helmy Eltoukhy bought shares on the open market in 2021 and 2023, and has not bought since 2023. Sales in 4 of the 8 years since 2019.
When did Helmy Eltoukhy last buy or sell shares?
In SEC filings since 2019: the latest open-market purchase is from 2023; the latest open-market sale is from 2025.
Which companies has Helmy Eltoukhy traded as an insider?
Guardant Health (GH), from 2019 to 2025: 10 purchases and 192 sales.